| Association of cannabis use in adolescence and risk of depression, anxiety, and suicidality in young adulthood: a systematic review and meta-analysis G Gobbi, T Atkin, T Zytynski, S Wang, S Askari, J Boruff, M Ware, ... JAMA psychiatry 76 (4), 426-434, 2019 | 836 | 2019 |
| Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis G Gobbi, FR Bambico, R Mangieri, M Bortolato, P Campolongo, M Solinas, ... Proceedings of the National Academy of Sciences 102 (51), 18620-18625, 2005 | 793 | 2005 |
| Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype C Heurteaux, G Lucas, N Guy, M El Yacoubi, S Thümmler, XD Peng, ... Nature neuroscience 9 (9), 1134-1141, 2006 | 441 | 2006 |
| Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex FR Bambico, N Katz, G Debonnel, G Gobbi Journal of Neuroscience 27 (43), 11700-11711, 2007 | 401 | 2007 |
| Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain D De Gregorio, RJ McLaughlin, L Posa, R Ochoa-Sanchez, J Enns, ... Pain 160 (1), 136-150, 2019 | 380 | 2019 |
| Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function L Santarelli, G Gobbi, PC Debs, EL Sibille, P Blier, R Hen, MJS Heath Proceedings of the National Academy of Sciences 98 (4), 1912-1917, 2001 | 376 | 2001 |
| Drugs for insomnia beyond benzodiazepines: pharmacology, clinical applications, and discovery T Atkin, S Comai, G Gobbi Pharmacological reviews 70 (2), 197-245, 2018 | 362 | 2018 |
| Epilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based Review SBJ Brodie MJ, Besag F, Ettinger AB, Mula M, Gobbi G, Comai S, Aldenkamp AP Pharmacological Reviews 68 (3), 563-602, 2016 | 306 | 2016 |
| CCNP Award Paper: Unveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacology S Comai, G Gobbi Journal of Psychiatry and Neuroscience 39 (1), 6-21, 2014 | 222 | 2014 |
| Chronic exposure to cannabinoids during adolescence but not during adulthood impairs emotional behaviour and monoaminergic neurotransmission FR Bambico, NT Nguyen, N Katz, G Gobbi Neurobiology of disease 37 (3), 641-655, 2010 | 206 | 2010 |
| Anatomical and cellular localization of melatonin MT1 and MT2 receptors in the adult rat brain B Lacoste, D Angeloni, S Dominguez‐Lopez, S Calderoni, A Mauro, ... Journal of pineal research 58 (4), 397-417, 2015 | 205 | 2015 |
| Spadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design J Mazella, O Pétrault, G Lucas, E Deval, S Béraud-Dufour, C Gandin, ... PLoS biology 8 (4), e1000355, 2010 | 205 | 2010 |
| Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation P Blier, G Gobbi, JE Turcotte, C de Montigny, N Boucher, C Hébert, ... European Neuropsychopharmacology 19 (7), 457-465, 2009 | 200 | 2009 |
| The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants MN Hill, CJ Hillard, FR Bambico, S Patel, BB Gorzalka, G Gobbi Trends in pharmacological sciences 30 (9), 484-493, 2009 | 195 | 2009 |
| Hallucinogens in mental health: preclinical and clinical studies on LSD, psilocybin, MDMA, and ketamine D De Gregorio, A Aguilar-Valles, KH Preller, BD Heifets, M Hibicke, ... Journal of Neuroscience 41 (5), 891-900, 2021 | 191 | 2021 |
| Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study G Gobbi, DL Murphy, KP Lesch, P Blier Journal of Pharmacology and Experimental Therapeutics 296 (3), 987-995, 2001 | 189 | 2001 |
| Psychedelics in psychiatry: neuroplastic, immunomodulatory, and neurotransmitter mechanisms A Inserra, D De Gregorio, G Gobbi Pharmacological Reviews 73 (1), 202-277, 2021 | 172 | 2021 |
| The psychopharmacology of aggressive behavior: a translational approach: part 1: neurobiology S Comai, M Tau, G Gobbi Journal of clinical psychopharmacology 32 (1), 83-94, 2012 | 169 | 2012 |
| Decline in serotonergic firing activity and desensitization of 5-HT1A autoreceptors after chronic unpredictable stress FR Bambico, NT Nguyen, G Gobbi European Neuropsychopharmacology 19 (3), 215-228, 2009 | 162 | 2009 |
| The psychopharmacology of aggressive behavior: a translational approach: part 2: clinical studies using atypical antipsychotics, anticonvulsants, and lithium S Comai, M Tau, Z Pavlovic, G Gobbi Journal of clinical psychopharmacology 32 (2), 237-260, 2012 | 155 | 2012 |
Stefano ComaiNeurobiological Psychiatry Unit, Department of Psychiatry, McGill University, Montreal, Qc, CanadaVerified email at mail.mcgill.ca
